Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 4;25(1):651.
doi: 10.3390/ijms25010651.

The Influence of Genetic Polymorphisms on the Expression of Interleukin-1beta, Prostaglandin E2 and Tumor Necrosis Factor Alpha in Peri-Implant Crevicular Fluid: A Cross-Sectional Study

Affiliations

The Influence of Genetic Polymorphisms on the Expression of Interleukin-1beta, Prostaglandin E2 and Tumor Necrosis Factor Alpha in Peri-Implant Crevicular Fluid: A Cross-Sectional Study

José Maria Cardoso et al. Int J Mol Sci. .

Abstract

The aim of this study was to evaluate the possible relationships between polymorphisms in the interleukin-1 (IL-1) A, IL-1B, and IL-1RN genes and concentrations of the inflammatory mediators IL-1β, tumor necrosis factor-alpha (TNF-α), and prostaglandin E2 (PGE2) in peri-implant crevicular fluid (PICF). A cross-sectional analytical study was conducted on 51 patients with dental implants. Samples from the buccal mucosa were obtained, and genetic analysis was performed using the real-time polymerase chain reaction (PCR) technique for IL-1A and IL-1B and PCR and restriction fragment length polymorphism analysis for IL-1RN. For the biochemical analysis, the concentrations of IL-1β and TNF-α were analyzed using multiplexed fluorescent sphere immunoassays, and PGE2 by enzyme-linked immunosorbent assay. In patients with detected IL-1RN polymorphism, there was an increase in the concentration of the three mediators with statistically significant differences in the mean values of TNF-α and PGE2, regardless of peri-implant health status (p = 0.002 and p = 0.049, respectively). The concentrations of all three mediators were positively and significantly correlated (IL-1β vs. TNF-α Rho = 0.480, p < 0.001; IL-1β vs. PGE2 Rho = 0.382, p = 0.006; and TNF-α vs. PGE2 Rho = 0.528, p < 0.001). We can conclude that the IL-1RN polymorphism exerts an influence on the PICF immune response, which may explain the influence of this genetic polymorphism on the occurrence of peri-implantitis.

Keywords: dental implants; genotype; interleukin-1; interleukin-1alpha; peri-implantitis; polymorphisms.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Figures

Scheme 1
Scheme 1
Potential impact of Interleukin-1 (IL-1) in the pathogenesis of inflammatory diseases.

Similar articles

Cited by

References

    1. Pjetursson B.E., Thoma D., Jung R., Zwahlen M., Zembic A. A Systematic Review of the Survival and Complication Rates of Implant-Supported Fixed Dental Prostheses (FDPs) after a Mean Observation Period of at Least 5 Years. Clin. Oral. Implants Res. 2012;23((Suppl. S6)):22–38. doi: 10.1111/j.1600-0501.2012.02546.x. - DOI - PubMed
    1. Romanos G.E., Delgado-Ruiz R., Sculean A. Concepts for Prevention of Complications in Implant Therapy. Periodontol. 2000. 2019;81:7–17. doi: 10.1111/prd.12278. - DOI - PubMed
    1. Jepsen S., Berglundh T., Genco R., Aass A.M., Demirel K., Derks J., Figuero E., Giovannoli J.L., Goldstein M., Lambert F., et al. Primary Prevention of Peri-Implantitis: Managing Peri-Implant Mucositis. J. Clin. Periodontol. 2015;42((Suppl. S16)):S152–S157. doi: 10.1111/jcpe.12369. - DOI - PubMed
    1. Berglundh T., Armitage G., Araujo M.G., Avila-Ortiz G., Blanco J., Camargo P.M., Chen S., Cochran D., Derks J., Figuero E., et al. Peri-Implant Diseases and Conditions: Consensus Report of Workgroup 4 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J. Clin. Periodontol. 2018;45((Suppl. S20)):S286–S291. doi: 10.1111/jcpe.12957. - DOI - PubMed
    1. Lang N.P., Berglundh T., Working Group 4 of Seventh European Workshop on Periodontology Periimplant Diseases: Where Are We Now?—Consensus of the Seventh European Workshop on Periodontology. J. Clin. Periodontol. 2011;38((Suppl. S11)):178–181. doi: 10.1111/j.1600-051X.2010.01674.x. - DOI - PubMed

MeSH terms

LinkOut - more resources